Frontlight ResearchEarly access
Trial site
National Institute Of Health
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Cervical cancer1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Lung cancer1 trial
- Mantle cell lymphoma1 trial
- Melanoma1 trial
- Neuroendocrine tumours1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 23 trials
- Phase 42 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed1 trial
- Lead sponsor
- Pharming Technologies B.V.2 trials
- Precigen, Inc2 trials
- Exelixis1 trial
- Novartis Pharmaceuticals1 trial
- Nurix Therapeutics, Inc.1 trial
Running trials
Recruiting
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Recruiting
Active, not recruiting
Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation
Recruiting
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Cervical cancer1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
- Neuroendocrine tumours1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026